ATAI Life Sciences NV
NASDAQ:ATAI

Watchlist Manager
ATAI Life Sciences NV Logo
ATAI Life Sciences NV
NASDAQ:ATAI
Watchlist
Price: 1.37 USD 1.48% Market Closed
Market Cap: 229.9m USD
Have any thoughts about
ATAI Life Sciences NV?
Write Note

ATAI Life Sciences NV
Note Receivable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

ATAI Life Sciences NV
Note Receivable Peer Comparison

Comparables:
BAYN
MRK
93M1
DMP
PSG

Competitive Note Receivable Analysis
Latest Figures & CAGR of Competitors

Company Note Receivable CAGR 3Y CAGR 5Y CAGR 10Y
ATAI Life Sciences NV
NASDAQ:ATAI
Note Receivable
$11.3m
CAGR 3-Years
78%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bayer AG
XETRA:BAYN
Note Receivable
€1.3B
CAGR 3-Years
1%
CAGR 5-Years
17%
CAGR 10-Years
11%
Merck KGaA
XETRA:MRK
Note Receivable
€35m
CAGR 3-Years
-4%
CAGR 5-Years
22%
CAGR 10-Years
N/A
MPH Health Care AG
XETRA:93M1
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dermapharm Holding SE
XETRA:DMP
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
PharmaSGP Holding SE
XETRA:PSG
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is ATAI Life Sciences NV's Note Receivable?
Note Receivable
11.3m USD

Based on the financial report for Dec 31, 2023, ATAI Life Sciences NV's Note Receivable amounts to 11.3m USD.

What is ATAI Life Sciences NV's Note Receivable growth rate?
Note Receivable CAGR 3Y
78%

Over the last year, the Note Receivable growth was 55%. The average annual Note Receivable growth rates for ATAI Life Sciences NV have been 78% over the past three years .

Back to Top